Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Willdan Group
WLDN
$1.29B
| $994K | ﹤0.01% |
27,921
+839
| +3% | +$31.6K |
|
2877
Centrus Energy
LEU
$3.83B
| $993K | ﹤0.01% |
25,673
+2,426
| +10% | +$67.3K |
|
2878
Citizens & Northern Corp
CZNC
$466M
| $981K | ﹤0.01% |
38,801
-44
| -0.1% | -$1.1K |
|
|
BVH
2879
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $979K | ﹤0.01% |
37,926
-66,126
| -64% | -$1.37M |
|
2880
Atossa Therapeutics
ATOS
$25.5M
| $977K | ﹤0.01% |
19,962
+365
| +2% | +$21.2K |
|
2881
Clene
CLNN
$53.5M
| $976K | ﹤0.01% |
7,141
-229
| -3% | -$39.1K |
|
2882
CleanSpark
CLSK
$2.96B
| $976K | ﹤0.01% |
84,144
+2,171
| +3% | +$29.2K |
|
|
ITIC
2883
Investors Title Co
ITIC
$534M
| $973K | ﹤0.01% |
5,325
-377
| -7% | -$67.9K |
|
2884
Miller Industries
MLR
$640M
| $972K | ﹤0.01% |
28,526
+852
| +3% | +$31.4K |
|
2885
Carter Bankshares
CARE
$757M
| $971K | ﹤0.01% |
68,234
-102,644
| -60% | -$1.27M |
|
|
ICVX
2886
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $970K | ﹤0.01% |
+32,757
| New | +$1.11M |
|
2887
Kopin
KOPN
$898M
| $969K | ﹤0.01% |
188,850
-974
| -0.5% | -$5.91K |
|
|
RYZ
2888
Ryerson Holding Corp
RYZ
$1.5B
| $957K | ﹤0.01% |
42,941
| – | – |
|
2889
Cartesian Therapeutics
RNAC
$264M
| $956K | ﹤0.01% |
7,657
+218
| +3% | +$26.3K |
|
2890
TETRA Technologies
TTI
$1.25B
| $956K | ﹤0.01% |
306,300
-1,888
| -0.6% | -$6.06K |
|
2891
Ezcorp Inc
EZPW
$1.76B
| $955K | ﹤0.01% |
126,134
-238,926
| -65% | -$1.53M |
|
2892
Kartoon Studios
TOON
$38.2M
| $955K | ﹤0.01% |
70,156
-304
| -0.4% | -$4.73K |
|
2893
Alaunos Therapeutics
TCRT
$4.86M
| $952K | ﹤0.01% |
3,487
-6,372
| -65% | -$1.95M |
|
|
EAR
2894
DELISTED
Eargo, Inc. Common Stock
EAR
| $951K | ﹤0.01% |
7,058
+2,506
| +55% | +$1.34M |
|
2895
Dorian LPG
LPG
$1.95B
| $946K | ﹤0.01% |
76,238
-119,055
| -61% | -$1.49M |
|
|
RRD
2896
DELISTED
RR Donnelley & Sons Co.
RRD
| $943K | ﹤0.01% |
183,438
+3,343
| +2% | +$17.8K |
|
2897
Motorcar Parts of America
MPAA
$235M
| $942K | ﹤0.01% |
48,294
-81,058
| -63% | -$1.7M |
|
2898
Bridgewater Bancshares
BWB
$620M
| $941K | ﹤0.01% |
53,739
-93,875
| -64% | -$1.52M |
|
2899
Barnes & Noble Education
BNED
$424M
| $940K | ﹤0.01% |
941
+7
| +0.7% | +$6.17K |
|
2900
Allient
ALNT
$1.86B
| $938K | ﹤0.01% |
29,983
+83
| +0.3% | +$2.71K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.